Bioventus Newsroom

JP Morgan Upgrades Bioventus to Neutral, Raises Price Target to $13

BenzingaDec 17 07:17 ET

Bioventus: Strategic Moves Amidst Financial Challenges Justify Hold Rating

TipRanksDec 17 05:38 ET

J.P. Morgan Upgrades Bioventus(BVS.US) to Hold Rating, Raises Target Price to $13

Moomoo NewsDec 17 05:34 ET

Bioventus Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 6 12:58 ET

Bioventus Analyst Ratings

BenzingaNov 6 12:49 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $17

Moomoo NewsNov 6 09:34 ET

CCORF Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $15

Moomoo NewsNov 6 08:39 ET

Bioventus (BVS) Gets a Sell From J.P. Morgan

TipRanksNov 6 07:31 ET

J.P. Morgan Maintains Bioventus(BVS.US) With Sell Rating, Announces Target Price $12

Moomoo NewsNov 6 07:31 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating

Moomoo NewsNov 5 09:37 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating

Moomoo NewsNov 4 09:31 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating

Moomoo NewsOct 2 08:36 ET

CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsOct 1 18:31 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $17

Moomoo NewsSep 27 09:31 ET

Analysts Are Bullish on These Healthcare Stocks: Bioventus (BVS), Sight Sciences (SGHT)

TipRanksSep 27 09:02 ET

Bioventus Analyst Ratings

BenzingaAug 13 08:05 ET

CCORF Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsAug 13 07:33 ET

Bioventus Analyst Ratings

BenzingaAug 7 12:14 ET

Buy Rating Affirmed: Bioventus's Strong Q2 Performance and Strategic Growth Outlook

TipRanksAug 7 07:43 ET

Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating

Moomoo NewsAug 5 09:31 ET